desloratadine has been researched along with Chronic Disease in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 19 (47.50) | 29.6817 |
2010's | 20 (50.00) | 24.3611 |
2020's | 1 (2.50) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Chen, X; Li, J; Liu, Z; Peng, C; Su, J; Zhang, W; Zhu, W | 1 |
Ben Chibani, J; Helal, AN; Kassab, A; Leban, N; Maouia, A; Youssef, M | 1 |
Yang, X; Zheng, D | 1 |
Chaowattanapanit, S; Choonhakarn, C; Julanon, N | 1 |
Chen, X; He, Y; Li, Q; Luo, Y; Yan, J; Yan, S | 1 |
Chen, M; Chen, W; Chen, X; Li, F; Li, J; Li, Q; Liu, Z; Peng, C; Su, J; Yan, S; Zhang, J; Zhang, W; Zhu, W | 1 |
Wang, J; Yan, X; Zhao, Y | 1 |
Arribas Granados, MP; Francés, L; Leiva-Salinas, M; Marin-Cabanas, I; Silvestre, JF | 1 |
Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Li, J; Liu, Z; Su, J; Wen, S; Yan, S; Zeng, W; Zhang, C; Zhang, J; Zhao, Y; Zhou, H; Zhu, W | 1 |
Barkai, L; Izquierdo, I; Maurer, M; Mezei, G; Mitha, E; Potter, P; Santamaría, E | 1 |
Kennedy, DW | 1 |
Bessis, D; Raison-Peyron, N; Reymann, V | 1 |
Bin, L; Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Leung, DY; Li, J; Liu, Z; Peng, C; Su, J; Yan, S; Yi, M; Zeng, W; Zhang, J; Zhang, W; Zhu, W | 1 |
Ciebiada, M; Ciebiada, MG; DuBuske, LM; Gorski, P; Kmiecik, T | 1 |
Finlay, AY; Guillet, G; Hauptmann, P; Jian, AM; Kapp, A; Maurer, M; Potter, PC | 1 |
Auquier, P; Dreyfus, I; Grob, JJ; Ortonne, JP | 3 |
Augustin, M; Ehrle, S | 1 |
Baskan, EB; Budak, F; Erturk, E; Gul, OO; Hacioglu, S; Imamoglu, S; Kiyici, S | 1 |
Bachert, C; Maurer, M | 1 |
Church, DS; Church, MK; Dimitrov, V; Kraeva, S; Kralimarkova, T; Lazarova, C; Popov, TA; Popova, D; Staevska, M | 1 |
Bérard, F; Boulinguez, S | 1 |
Eigelshoven, S; Homey, B; Korkmaz, H | 1 |
Chu, CY; Hong, JB; Hu, FC; Lee, HC | 1 |
Chu, CY; Hong, JB; Lee, HC | 1 |
Langner, C; Siegel, C; Thonhofer, R; Trummer, M | 1 |
Monroe, EW | 1 |
Bernstein, D; Finn, A; Guerrero, R; Monroe, E; Patel, P; Ratner, P | 1 |
Colanardi, MC; Ferrannini, A; Nettis, E; Paradiso, MT | 1 |
Di Lorenzo, G; Ditta, V; Esposito Pellitteri, M; Lo Bianco, C; Mansueto, P; Martinelli, N; Pacor, ML; Rini, GB | 1 |
Elbirt, D; Rottem, M; Sthoeger, Z | 1 |
DuBuske, LM | 1 |
Boonen, H; De Swerdt, A; Decroix, J; Henrijean, A; Lachapelle, JM; Lecuyer, M; Roquet-Gravy, PP; Speelman, G; Suys, E; Vastesaeger, N | 1 |
Amoruso, A; Cassano, N; D'Argento, V; Filieri, M; Filotico, R; Raho, G; Vena, GA | 1 |
Lam, HC; Tong, MC; Van Hasselt, CA | 1 |
DuBuske, L | 1 |
Abdalla, AN; Khalaf, AT; Liu, XM; Sheng, WX; Tan, JQ | 1 |
Gauger, A; Hein, R; Ring, J | 1 |
Bronsky, E; Gauger, A; Hein, R; Miller, B; Ring, J | 1 |
6 review(s) available for desloratadine and Chronic Disease
Article | Year |
---|---|
Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
Topics: Activities of Daily Living; Adult; Anti-Allergic Agents; Chronic Disease; Female; Germany; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Nasal Obstruction; Pregnancy; Product Surveillance, Postmarketing; Pruritus; Rhinitis, Allergic, Seasonal; Sleep; Sneezing; Structure-Activity Relationship; Treatment Outcome; Urticaria | 2010 |
[Diagnostic and physiopathological innovations related to chronic urticaria].
Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoantibodies; Autoimmune Diseases; Blood Coagulation; Chronic Disease; Drug Eruptions; Female; Histamine H1 Antagonists, Non-Sedating; Histamine Release; Humans; Iodide Peroxidase; Loratadine; Mast Cells; Middle Aged; Omalizumab; Penicillins; Urticaria | 2010 |
Desloratidine for the treatment of chronic urticaria.
Topics: Chronic Disease; Histamine H1 Antagonists; Humans; Loratadine; Urticaria | 2002 |
Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents; Asthma; Child; Child, Preschool; Chronic Disease; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Loratadine; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria | 2005 |
Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
Topics: Acetates; Adolescent; Adult; Child; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Leukotriene Antagonists; Loratadine; Quality of Life; Quinolines; Sulfides; Urticaria | 2007 |
Desloratadine in the treatment of chronic idiopathic urticaria.
Topics: Cholinergic Antagonists; Chronic Disease; Cytokines; Histamine H1 Antagonists; Humans; Loratadine; Severity of Illness Index; Time Factors; Treatment Outcome; Urticaria | 2001 |
22 trial(s) available for desloratadine and Chronic Disease
Article | Year |
---|---|
Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.
Topics: Adult; China; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Histamine H1; Severity of Illness Index; Sleepiness; Treatment Outcome; Urticaria | 2020 |
CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; C-Reactive Protein; Catalase; Chronic Disease; Female; Glutathione Peroxidase; Glutathione Transferase; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Severity of Illness Index; Superoxide Dismutase; Tunisia; Urticaria; Young Adult | 2017 |
Clinical observation on the therapeutic effect of desloratadine citrate disodium in the treatment of chronic urticaria and changes in IL4, IL18, IL23 and IL-33 levels before and after treatment.
Topics: Adolescent; Adult; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Interleukin-18; Interleukin-23; Interleukin-33; Interleukin-4; Loratadine; Male; Middle Aged; Urticaria; Young Adult | 2017 |
Effects of Desloratadine Citrate Disodium on Serum Immune Function Indices, Inflammatory Factors and Chemokines in Patients with Chronic Urticaria.
Topics: Administration, Oral; Adult; Biomarkers; Chemokine CCL5; Chemokines; China; Cholinergic Antagonists; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukins; Loratadine; Male; Middle Aged; Reference Values; Treatment Outcome; Urticaria | 2019 |
Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Topics: Age Factors; Child; Child, Preschool; Chronic Disease; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hungary; Loratadine; Male; Quality of Life; Remission Induction; South Africa; Time Factors; Treatment Outcome; Urticaria | 2016 |
Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Topics: Acetates; Adolescent; Adult; Aged; Cetirizine; Chronic Disease; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Interactions; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Quality of Life; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome | 2008 |
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Pruritus; Quality of Life; Severity of Illness Index; Urticaria | 2009 |
How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
Topics: Adult; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Quality of Life; Urticaria | 2009 |
Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity.
Topics: Adolescent; Adult; Autoimmune Diseases; Chi-Square Distribution; Chronic Disease; Drug Combinations; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hypothyroidism; Interferon-gamma; Interleukin-10; Loratadine; Male; Middle Aged; Prospective Studies; Thyroxine; Treatment Outcome; Tumor Necrosis Factor-alpha; Urticaria; Young Adult | 2010 |
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Topics: Adult; Aged; Cetirizine; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Quality of Life; Urticaria; Young Adult | 2010 |
A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Pilot Projects; Sleep Stages; Urticaria | 2010 |
Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Child; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Urticaria | 2003 |
Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Pruritus; Quality of Life; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome; Urticaria | 2004 |
Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Topics: Acetates; Adolescent; Adult; Aged; Chronic Disease; Cyclopropanes; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Quinolines; Sulfides; Treatment Outcome; Urticaria | 2004 |
[Desloratadine for chronic idiopathic urticaria].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Israel; Loratadine; Male; Middle Aged; Patient Satisfaction; Surveys and Questionnaires; Urticaria | 2005 |
Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
Topics: Administration, Oral; Adult; Belgium; Chronic Disease; Drug Administration Schedule; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Quality of Life; Severity of Illness Index; Treatment Outcome; Urticaria | 2006 |
Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria.
Topics: Adult; Aged; Biomarkers; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Severity of Illness Index; Superoxide Dismutase; Urticaria | 2006 |
Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Pruritus; Severity of Illness Index; Treatment Outcome; Urticaria | 2007 |
Rhinitis symptoms and quality of life in patients with chronic perennial rhinitis treated with desloratadine.
Topics: Adult; Chronic Disease; Endoscopy; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Prospective Studies; Quality of Life; Rhinitis, Allergic, Perennial; Severity of Illness Index; Treatment Outcome | 2007 |
Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Dipyridamole; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Platelet Aggregation Inhibitors; Skin Tests; Treatment Outcome; Urticaria | 2008 |
Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
Topics: Activities of Daily Living; Adult; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Outcome Assessment, Health Care; Quality of Life; Sleep; Treatment Outcome; Urticaria | 2008 |
Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Cholinergic Antagonists; Chronic Disease; Dizziness; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Headache; Humans; Loratadine; Male; Middle Aged; Pharyngitis; Pruritus; Respiratory Tract Infections; Treatment Outcome; Urticaria; Virus Diseases | 2001 |
12 other study(ies) available for desloratadine and Chronic Disease
Article | Year |
---|---|
The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria.
Topics: Adult; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Maintenance Chemotherapy; Male; Middle Aged; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Treatment Outcome; Urticaria; Young Adult | 2018 |
[Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria].
Topics: Calcium Channels, L-Type; Chronic Disease; Genetic Predisposition to Disease; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Urticaria | 2018 |
C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level.
Topics: Adolescent; Adult; Aged; Animals; Benzimidazoles; C-Reactive Protein; China; Chronic Disease; Chronic Urticaria; Female; Gene Expression; Genotype; HEK293 Cells; Histamine H1 Antagonists; Humans; Interleukin-6; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Rats; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2019 |
Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C.
Topics: Anti-Allergic Agents; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Middle Aged; Omalizumab; Urticaria | 2015 |
Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Topics: Adolescent; Adult; Aged; Asian People; Benzimidazoles; Case-Control Studies; China; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Receptor, Anaphylatoxin C5a; Risk Factors; Treatment Outcome; Urticaria; Young Adult | 2014 |
EDITORIAL.
Topics: Animals; Carcinogenesis; Chronic Disease; Diagnosis, Differential; Histamine Antagonists; Humans; Loratadine; Nasal Lavage; Nasal Mucosa; Nose Neoplasms; Papilloma, Inverted; Publishing; Rhinitis, Allergic; Sinusitis; Th1-Th2 Balance | 2015 |
Follicular Traction Urticaria: A New Form of Chronic Inducible Urticaria?
Topics: Administration, Oral; Biopsy; Chronic Disease; Drug Administration Schedule; Female; Hair Follicle; Hair Removal; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Physical Stimulation; Risk Factors; Tablets; Terminology as Topic; Treatment Outcome; Urticaria; Young Adult | 2017 |
Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine.
Topics: Adult; Chronic Disease; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; ORAI1 Protein; Polymorphism, Single Nucleotide; Urticaria | 2017 |
Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Sleep; Urticaria; Young Adult | 2009 |
[Omalizumab for therapy-resistant chronic urticaria with angioedema].
Topics: Adult; Angioedema; Anti-Allergic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Leukocytosis; Loratadine; Male; Omalizumab; Prednisolone | 2010 |
Chronic idiopathic urticaria in Taiwan: a clinical study of demographics, aggravating factors, laboratory findings, serum autoreactivity and treatment response.
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Taiwan; Treatment Outcome; Urticaria; Young Adult | 2011 |
Mastocytic enterocolitis as a rare cause of chronic diarrhea in a patient with rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Biopsy; Chronic Disease; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Enterocolitis; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Intestinal Mucosa; Loratadine; Male; Mast Cells; Mastocytosis; Methotrexate; Middle Aged; Ranitidine; Tryptases | 2011 |